-
Share
766 Posts.
167
02/04/21
06:30
Share
Hunt added there is also the potential for greater innovation in the area of bioavailability, citing Canntab’s instant and extended release hard-pill formulations as examples, but “those types of products take a lot of research and investment”.
Looks like CGB have a real winner on their hands
Zess looks like we will be years a head of the pack